Rentokil Initial Plc /Fi (RKLIF) Common Equity (2020 - 2025)

Rentokil Initial (RKLIF) has reported Common Equity for 6 consecutive years, with $5.5 billion the latest figure, recorded in Q4 2025.

• In Q4 2025, Common Equity rose 1.22% year-over-year to $5.5 billion; the TTM figure through Dec 2025 stood at $5.5 billion (up 1.22% YoY), while the FY2025 annual figure was $5.5 billion, up 3.8% from the prior year.
• Common Equity advanced to $5.5 billion in Q4 2025 per RKLIF's latest filing, from $232.0 million in the prior quarter.
• Across five years, Common Equity topped out at $5.5 billion in Q4 2025 and bottomed at $232.0 million in Q3 2025.
• Historically, Common Equity has averaged $4.0 billion across 5 years, with a median of $5.0 billion in 2023.
• Annual changes were most pronounced in 2022 — Common Equity jumped 182.1% — and 2025, when it gained 0.24%.
• Rentokil Initial's Common Equity stood at $1.7 billion in 2021, then jumped by 182.1% to $4.8 billion in 2022, then advanced by 5.56% to $5.1 billion in 2023, then advanced by 6.98% to $5.4 billion in 2024, then rose by 1.22% to $5.5 billion in 2025.
• Business Quant data shows RKLIF's Common Equity at $5.5 billion in Q4 2025, $232.0 million in Q3 2025, and $5.3 billion in Q2 2025.